Actively Recruiting
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Led by Vanderbilt University Medical Center · Updated on 2026-03-05
60
Participants Needed
1
Research Sites
94 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
CONDITIONS
Official Title
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-pregnant adults aged 18 years or older admitted to VUMC
- Able to give informed consent
- Hyperglycemia requiring insulin therapy (subcutaneous injection or insulin pump) during hospitalization and at discharge
- Point-of-care or venous glucose levels between 70-350 mg/dL in the 24 hours before participation
- Need glucose readings at least once per day
- Adequate mental status and dexterity to use Libre 3 Plus or Dexcom G7 sensors with corresponding smartphone apps
You will not qualify if you...
- Currently using or used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months
- No smartphone compatible with Libre 3 or Dexcom G7 apps
- Receiving chemotherapy during current hospitalization
- Planning major surgery within 10-15 days
- On hemodialysis or peritoneal dialysis
- Requiring vasopressors, intubation, sedation, or ICU admission
- Using more than 500 mg/day of Vitamin C
- Using hydroxyurea
- Using more than 4 grams/day of acetaminophen or more than 1 gram every 6 hours
- Significant pitting edema (3+ or greater) due to conditions like cirrhosis with ascites, heart failure with edema, nephrotic syndrome, or poor perfusion
- Presenting with diabetic ketoacidosis or hyperosmolar nonketotic state
- Allergic to skin adhesives
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
A
Angel Morvant, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here